Join us for our next online webinar in collaboration with AXXAM.
“Small modalities, deep impact”: VHH antibodies as complementary approaches for challenging therapeutic targets.
In this webinar, Isogenica and Axxam will discuss their newly formed strategic partnership, highlighting the combined strengths of Isogenica’s diverse VHH libraries and Axxam’s expertise in functional assay development and High-Throughput screening platforms. The session will also include examples showcasing the successful application of their respective capabilities.
Learn more and register HERE